➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
AstraZeneca
Harvard Business School
Medtronic

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sarcosine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Sarcosine?

Sarcosine is an investigational drug.

There have been 14 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.

There are two US patents protecting this investigational drug and thirty-two international patents.

Recent Clinical Trials for Sarcosine
TitleSponsorPhase
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTUniversity of AarhusEarly Phase 1
Carbon-11 Labeled Sarcosine in Prostate CancerNational Cancer Institute (NCI)N/A
Carbon-11 Labeled Sarcosine in Prostate CancerNational Institutes of Health (NIH)N/A

See all Sarcosine clinical trials

Clinical Trial Summary for Sarcosine

Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine

See all Sarcosine clinical trials

US Patents for Sarcosine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sarcosine   Start Trial Composition and method for removal of stains from fibers Harris Research, Inc. (Cameron Park, CA)   Start Trial
Sarcosine   Start Trial Process for the formation of an image Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
Sarcosine   Start Trial Substituted heterocyclohexane-3,5-diones Sandoz Ltd. (Basel, CH)   Start Trial
Sarcosine   Start Trial Method and articles employing ion exchange material Raychem Corporation (Menlo Park, CA)   Start Trial
Sarcosine   Start Trial General method for producing and selecting peptides with specific properties The Regents of the University of California (Oakland, CA)   Start Trial
Sarcosine   Start Trial Ionically modified agarose Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
Sarcosine   Start Trial Treatment of hypertension with 1,2,4-angiotensin II antagonists E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sarcosine

Drugname Country Document Number Estimated Expiration Related US Patent
Sarcosine Belgium 1002863 2007-04-11   Start Trial
Sarcosine Canada 1333855 2007-04-11   Start Trial
Sarcosine Germany 3811859 2007-04-11   Start Trial
Sarcosine France 2613848 2007-04-11   Start Trial
Sarcosine United Kingdom 2203564 2007-04-11   Start Trial
Sarcosine United Kingdom 8708747 2007-04-11   Start Trial
Sarcosine United Kingdom 8808267 2007-04-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Dow
Baxter
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.